AKT1 and metabolic syndrome: Additionally, chronic systemic inflammation associated with metabolic syndrome and smoking may influence signaling pathways such as NF-κB, PI3K/AKT, and mTOR, which are known to affect the translation efficiency and stability of neurotrophic factors.